FitMi AD Home Therapy for Individuals With MCI or Mild Dementia Due to Alzheimer's Disease

不适用 已完成 NCT05504811

摘要

This study will investigate the efficacy of a newly developed exercise device (FitMi AD) for individuals with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's disease. FitMi AD uses embedded sensors that can track and record the patient's direction and degree of movement while performing exercises described on a computer.

Change in Functional Reach Test

Baseline, Immediately Post-Treatment (an average of 3 months) · centimeters

Change in Timed Up and Go Test

Baseline, Immediately Post-Treatment (an average of 3 months) · Seconds

Change in 30 Second Chair Stand Test

Baseline, Immediately Post-Treatment (an average of 3 months) · number of times the patient stands in 30

在 BENITIONS 中查看 查看 ClinicalTrials.gov 原文

同一适应症的其他试验

• Brain Energy for Amyloid Transformation in Alzheimer's Disease Study — Wake Forest University Health Sciences
• Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss — Eli Lilly and Company
• Using a Wireless Controller to Deliver a Lighting Intervention to Persons With Dementia — Icahn School of Medicine at Mount Sinai
• Deprescribing in Patients Living With Dementia With Caregiver and Provider Nudges — Brigham and Women's Hospital
• Technology and Family Thriving Study — University of California, Santa Barbara
• Community-based Brain Health Program to Address Dementia Risk — Posit Science Corporation

全部试验